These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12540603)

  • 1. NOD congenic mice genetically protected from autoimmune diabetes remain resistant to transplantation tolerance induction.
    Pearson T; Markees TG; Wicker LS; Serreze DV; Peterson LB; Mordes JP; Rossini AA; Greiner DL
    Diabetes; 2003 Feb; 52(2):321-6. PubMed ID: 12540603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic disassociation of autoimmunity and resistance to costimulation blockade-induced transplantation tolerance in nonobese diabetic mice.
    Pearson T; Markees TG; Serreze DV; Pierce MA; Marron MP; Wicker LS; Peterson LB; Shultz LD; Mordes JP; Rossini AA; Greiner DL
    J Immunol; 2003 Jul; 171(1):185-95. PubMed ID: 12816997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice.
    Mangada J; Pearson T; Brehm MA; Wicker LS; Peterson LB; Shultz LD; Serreze DV; Rossini AA; Greiner DL
    Diabetes; 2009 Jan; 58(1):165-73. PubMed ID: 18984741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune diabetes and resistance to xenograft transplantation tolerance in NOD mice.
    Gordon EJ; Wicker LS; Peterson LB; Serreze DV; Markees TG; Shultz LD; Rossini AA; Greiner DL; Mordes JP
    Diabetes; 2005 Jan; 54(1):107-15. PubMed ID: 15616017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet allograft survival induced by costimulation blockade in NOD mice is controlled by allelic variants of Idd3.
    Pearson T; Weiser P; Markees TG; Serreze DV; Wicker LS; Peterson LB; Cumisky AM; Shultz LD; Mordes JP; Rossini AA; Greiner DL
    Diabetes; 2004 Aug; 53(8):1972-8. PubMed ID: 15277375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOD mice have a generalized defect in their response to transplantation tolerance induction.
    Markees TG; Serreze DV; Phillips NE; Sorli CH; Gordon EJ; Shultz LD; Noelle RJ; Woda BA; Greiner DL; Mordes JP; Rossini AA
    Diabetes; 1999 May; 48(5):967-74. PubMed ID: 10331399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
    Demirci G; Strom TB; Li XC
    J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.
    Molano RD; Berney T; Li H; Cattan P; Pileggi A; Vizzardelli C; Kenyon NS; Ricordi C; Burkly LC; Inverardi L
    Diabetes; 2001 Feb; 50(2):270-6. PubMed ID: 11272136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin allograft maintenance in a new synchimeric model system of tolerance.
    Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.
    Phillips NE; Markees TG; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2003 Mar; 170(6):3015-23. PubMed ID: 12626555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct genetic control of autoimmune neuropathy and diabetes in the non-obese diabetic background.
    Bour-Jordan H; Thompson HL; Giampaolo JR; Davini D; Rosenthal W; Bluestone JA
    J Autoimmun; 2013 Sep; 45():58-67. PubMed ID: 23850635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain.
    Koarada S; Wu Y; Fertig N; Sass DA; Nalesnik M; Todd JA; Lyons PA; Fenyk-Melody J; Rainbow DB; Wicker LS; Peterson LB; Ridgway WM
    J Immunol; 2004 Aug; 173(4):2315-23. PubMed ID: 15294944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral abrogation of stem cell transplantation tolerance causes graft rejection and host death by different mechanisms.
    Forman D; Welsh RM; Markees TG; Woda BA; Mordes JP; Rossini AA; Greiner DL
    J Immunol; 2002 Jun; 168(12):6047-56. PubMed ID: 12055213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.
    Thornley TB; Brehm MA; Markees TG; Shultz LD; Mordes JP; Welsh RM; Rossini AA; Greiner DL
    J Immunol; 2006 Feb; 176(3):1561-70. PubMed ID: 16424185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
    Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
    Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
    J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A therapeutic DNA vaccination strategy for autoimmunity and transplantation.
    Li A; Chen J; Hattori M; Franco E; Zuppan C; Ojogho O; Iwaki Y; Escher A
    Vaccine; 2010 Feb; 28(8):1897-904. PubMed ID: 20188244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody.
    Welsh RM; Markees TG; Woda BA; Daniels KA; Brehm MA; Mordes JP; Greiner DL; Rossini AA
    J Virol; 2000 Mar; 74(5):2210-8. PubMed ID: 10666251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.